Callan JMB Inc. (CJMB) Narxning foydaga nisbati

Callan JMB Inc (CJMB) xirurgik uskunalarining to'g'ridan-to'g'ri B2B yetkazib berishlari orqali, birlashmalarsiz nisha ustunligiga e'tibor qaratgan holda organik kengayishni ta'minlaydi. Tarixiy narxlar dinamikasi ushbu sektorning kuzatilishiga imkon beradi, bunda ko'rsatkich -0.20 darajasida turibdi. Biznes hozirda shakllanish bosqichida bo'lib, litsenziyalash xarajatlari daromadlardan oshib, FCF defitsitini yuzaga keltirmoqda. Shu bilan birga, klinikalarga tuzilgan uzoq muddatli kelishuvlar tufayli pul oqimlari asta-sekin kuchaymoqda.

Callan JMB (CJMB) - P/E multiplikatori 06.02.2025dan 10.11.2026gacha

Callan JMB Inc kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:callanjmb.com, CJMB

Investorlar ushbu koeffitsiyentdan aktivning foydasiga nisbatan haddan tashqari qimmat baholanganlik darajasini aniqlash uchun foydalanadilar. Ushbu metrika aksiyaning bozor qiymatining bir aksiya uchun foyda miqdoriga nisbati sifatida hisoblanadi. Kompaniyaning forward P/E koeffitsiyentini tahlil qilish orqali investitsiyalarning qoplanish muddatini baholash mumkin. Callan JMB Inc. (CJMB) kompaniyasining tushumlar barqarorligi klinikalarga tuzilgan uzoq muddatli shartnomalar bilan ta'minlanadi. Ekspert tibbiy uskuna xizmatlari fundamental ko'rsatkichlarning barqarorligini ta'minlaydi.

Raqobatdosh kompaniyalar tahlili

P/E multiplikatori intuitive.com|Narxning foydaga nisbati Danaher (DHR)|Narxning foydaga nisbati BDX (BD)|STERIS Corporation - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati WST|Baxter International - P/E multiplikatori|Biznesning o‘zini qoplash muddati masimo.com MASI|Stevanato Group (STVN) - Narxning foydaga nisbati|Narx-foyda multiplikatori TFX|Narxning foydaga nisbati Merit Medical Systems Inc|Nobel Biocare (NVST) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ICUI (ICU Medical, Inc.)|Bozor narxining sof foydaga nisbati XRAY|Narxning foydaga nisbati LeMaitre Vascular LMAT|Kompaniya qiymatining sof foydaga nisbati ATRC|STAA: Narx-foyda koeffitsiyenti|NAGE - P/E multiplikatori|ZimVie Inc. (ZIMV) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti angiodynamics.com|CERS (Cerus) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Alpha Teknova TKNO|Narxning foydaga nisbati Monogram Technologies Inc (MGRM)|sharpstechnology.com - Narx-foyda multiplikatori|InfuSystem Holdings, Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati UTMD (utahmed.com)|KRMD - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Nyxoah SA NYXH|MBOT: P/E multiplikatori|Narx-foyda koeffitsiyenti Pro-Dex Inc.|ZTEK (Zentek Ltd.) - P/E multiplikatori|P/E multiplikatori elutia.com|Narxning foydaga nisbati Milestone Scientific Inc. (MLSS)|Narxning foydaga nisbati NXGL (NEXGEL Inc.)|Narxning foydaga nisbati Retractable Technologies, Inc. RVP|harvardbioscience.com - Narxning foydaga nisbati|Femasys Inc. - P/E multiplikatori|MHUA - P/E multiplikatori|predictive-oncology.com (POAI) - Narxning foydaga nisbati|Narx-foyda multiplikatori ATRI|Narx-foyda koeffitsiyenti NURO